数字农科院2.0

Genome-wide CRISPR screens identify CLC-2 as a drug target for anti-herpesvirus therapy: tackling herpesvirus drug resistance

文献类型： 外文期刊

作者： Yang, Fayu;Wei, Nan;Cai, Shuo;Liu, Jing;Lan, Qingping;Zhang, Hao;Shang, Lu;Zheng, Bo;Wang, Mi;Liu, Yingchun;Zhang, Lifang;Fei, Chenzhong;Tong, Wu;Liu, Changlong;Kuang, Ersheng;Tong, Guangzhi;Gu, Feng

作者机构：

关键词： herpesviruses;CRISPR;host-directed therapy;CLC-2;DIDS

期刊名称： SCIENCE CHINA-LIFE SCIENCES

ISSN： 1674-7305

年卷期： 2024 年

页码：

收录情况： SCIE（2024版） ; ; CSCD（2023-2024年度） ; ; 科技核心（2024版）

摘要： The emergence of drug resistance to virus (i.e., acyclovir (ACV) to herpesviruses) has been termed one of the common clinical issues, emphasizing the discovery of new antiviral agents. To address it, a genome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screening was performed in mouse haploid embryonic stem cells infected with pseudorabies virus (PRV), an alpha-herpesvirus causing human and pig diseases. The results demonstrated that type 2 voltage-gated chloride channels (CLC-2) encoded by one of the identified genes, CLCN2, is a potential drug target for anti-herpesvirus therapy. CLC-2 inhibitors, omeprazole (OME) and 4,4 '-diisothiocyanostilbene-2,2 '-disulfonic acid (DIDS), can efficiently inhibit infection of multiple herpesviruses in cellulo (i.e., PRV, HSV and EBV), and effectively treat murine herpes simplex encephalitis (HSE). Additionally, DIDS was found to inhibit HSV-1 replication by blocking the PI3K/Akt pathway. Most importantly, both DIDS and OME were able to inhibit ACV-resistant HSV-1 strain infection. The study's findings suggest that targeting host-cell factors such as CLC-2 may be a promising approach to tackling herpesvirus drug resistance. The discovery of CLC-2 as a potential drug target for anti-herpesvirus therapy provides a new direction for the development of novel antiviral agents.

分类号：

  • 相关文献

[1]运用CRISPR/Cas系统对植物基因组进行定点编辑. 宋时奎,王影,于洋,耿立召,张春翔,李相敢,韩天富. 2014

[2]基因编辑技术及其在作物育种中的应用与安全管理. ,,龙艳,,裴新梧. 2018

[3]CRISPR技术在病毒学研究中的应用. 高帅,李芳,李赞,王涛,赵东明,步志高. 2020

[4]基于专利文献的全球CRISPR技术研发进展分析与展望. 王友华1 邹婉侬1 张熠2 樊君丽3 孙国庆1. 2018

[5]利用CRISPR技术鉴定拟南芥miR171a的功能. 黄格格,张静文,张天豹,柯智,翟楠鑫,龙艳,袁潜华,裴新梧. 2019

[6]基于CRISPR的快速灵敏便捷分子检测. 孙雯君,黄行许,王鑫杰. 2023

[7]基于CRISPR系统的基因编辑技术的研究进展. 郑基坛(综述),闫娜娜,左二伟(审校). 2021

[8]水稻CRISPR/Cas12a系统的优化及其介导的腺嘌呤碱基编辑器的建立. 王敬文,严芳,柳浪,周雪平,王道文,周焕斌. 2021

[9]CRISPR相关技术在肉牛领域的研究进展. 吴天弋,党靖宇,王添祯,张路培,高雪,李俊雅,徐凌洋. 2023

[10]基于CRISPR/CasX介导的水稻基因编辑技术的建立. 李雪琪,张素杰,于曼,黄金光,周焕斌. 2023

[11]基于CRISPR/LanCas9的水稻基因编辑系统的开发和优化. 李欣格,王美霞,王晨阳,马桂根,周常勇,王亚南,周焕斌. 2024

[12]植物线粒体基因组编辑研究进展. 张硕,阚俊虎,周家伟,武志强. 2024

[13]家禽基因编辑相关技术研究进展及应用. 冉明霞,郑基坛,刘兴廷,谢龙,左二伟,陆阳清. 2024

[14]RUBY辅助的水稻高效CRISPR基因编辑. 邓美壁,严浪,詹志田,朱敏,和玉兵. 2025

[15]绵羊无浆体LAMP-CRISPR/Cas12a检测方法的建立. 郭心龙,周勇志,曹杰,王亚楠,张厚双,段德勇,周金林. 2024

[16]Hi-Tom: A Platform For High-Throughput T.racking Of Mutations Induced B y Crispr/Cas Systems. Gao, Caixia,Liu, Qing,Zhang, Huawei,Wang, Kejian,Song, Lili,Jiao, Xiaozhen,Wang, Chun,Li, Yanxin. 2019

[17]CRISPR/Cas9 editing characteristics of multiple transgenic generations in Fortunella hindsii, an early flowering mini-citrus. Song, Xietian,Xie, Yuanyuan,Tian, Xiaoyu,Wang, Nan,Zhou, Yin,Xie, Zongzhou,Ye, Junli,Deng, Xiuxin. 2023

[18]CRISPR/Cas9-targeted mutagenesis of TaDCL4, TaDCL5 and TaRDR6 induces male sterility in common wheat. Zhang, Rongzhi,Zhang, Shujuan,Li, Jihu,Gao, Jie,Song, Guoqi,Li, Wei,Geng, Shuaifeng,Liu, Cheng,Lin, Yanxiang,Li, Yulian,Li, Genying. 2023

[19]Supersweet And Waxy: Meeting The D.iverse Demands For Specialty M aize By Genome Editing. Dong, L, Qi, XT, Zhu, JJ, Liu, CL, Zhang, X, Cheng, BJ, Mao, L, Xie, CX. 2019

[20]Crispr/Cas9-Mediated Targeted Mutagenesis Of Gmspl9 G.enes Alters Plant Architecture I n Soybean. Bao, AL, Chen, HF, Chen, LM, Chen, SL, Hao, QN, Guo, W, Qiu, DZ, Shan, ZH, Yang, ZL, Yuan, SL, Zhang, CJ, Zhang, XJ, Liu, BH, Kong, FJ, Li, X, Zhou, XA, Tran, LSP, Cao, D. 2019

作者其他论文 更多>>